SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec - Quaterly Results

14 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 1084.30 millions, about 13.86% up against Rs. 952.30 millions recorded during the year-ago period.Net Profit for the quarter ended December 2024 zoomed to 2144.19% from Rs. 4.30 millions to Rs. 96.50  millions.The company reported a good operating profit of 187.10 millions compared to 96.90 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1084.30 952.30 13.86 2419.50 2792.30 -13.35 3596.00 2570.70 39.88
Other Income 33.20 30.50 8.85 105.30 85.20 23.59 249.10 344.30 -27.65
PBIDT 187.10 96.90 93.09 221.70 319.30 -30.57 390.80 -281.90 -238.63
Interest 38.50 34.10 12.90 108.20 104.20 3.84 137.80 100.60 36.98
PBDT 148.60 62.80 136.62 113.50 215.10 -47.23 253.00 -382.50 -166.14
Depreciation 52.10 52.10 0.00 153.80 159.50 -3.57 210.90 245.00 -13.92
PBT 96.50 10.70 801.87 -40.30 55.60 -172.48 42.10 -627.50 -106.71
TAX 0.00 6.40 0.00 -11.90 6.40 -285.94 6.60 247.90 -97.34
Deferred Tax 0.00 0.00 0.00 -11.90 0.00 0.00 0.20 247.90 -99.92
PAT 96.50 4.30 2144.19 -28.40 49.20 -157.72 35.50 -875.40 -104.06
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 17.26 10.18 69.58 9.16 11.44 -19.87 10.87 -10.97 -199.10

Panacea Biotec Share Price

342.05 -15.95 (-4.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×